Sort
53,477 grants matching “addiction”
Project 1
$766,758Bruce W Stillman · Cold Spring Harbor Laboratory · P01 · FY2017 · CA
Neuroimaging response inhibition and salience attribution changes during mindfulness-based treatment of human heroin addiction
$766,743Rita Z Goldstein · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · AT
Treatment of Chemotherapy-Induced Peripheral Neuropathy via Genetic Repression of Sodium Channels
$766,685Fernando Aleman Guillen · Navega Therapeutics, Inc. · R44 · FY2021 · CA
Using Sleep Health to Optimize Smoking Cessation Treatment Response in HIV-Positive Adults
$766,569Elizabeth Connick · University Of Arizona · R01 · FY2022 · DA
Phase 2 Selective DAT inhibitor for treatment of Obesity.
$766,488Frank Zemlan · P2d, Inc. · R44 · FY2011 · DK
Services Research: Psychiatric Comorbidity in Drug Abuse
$766,390Johns Hopkins University · R01 · FY2003 · DA
Clinical Core
$766,360Henry Richard Kranzler · University Of Pennsylvania · P30 · FY2020 · DA
Clinical Trials Network: The Texas Node
$766,319Madhukar H Trivedi · Ut Southwestern Medical Center · UG1 · FY2019 · DA
Clinical Trials Network: The Texas Node
$766,319Madhukar H Trivedi · Ut Southwestern Medical Center · UG1 · FY2018 · DA
Vancouver Drug Users Study: Evaluating the Natural History of Injection Drug Use
$766,270Thomas Kerr · University Of British Columbia · U01 · FY2015 · DA
Endocannabinoid roles in neurochemical and reinforcing effects of abused drugs
$766,152Gianluigi Tanda · National Institute On Drug Abuse · ZIA · FY2018 · DA
Drug Abuse Training Program
$766,040Jacqueline F. McGinty · Medical University Of South Carolina · T32 · FY2020 · DA
Multi-modal profiling of spatially resolved cell types mediating opioid withdrawal
$765,953Xiaoke Chen · Stanford University · R01 · FY2023 · DA
cART, neuroHIV, cocaine abuse and the mPFC neuron/astrocyte dysfunction
$765,908Xiu-Ti Hu · Rush University Medical Center · R01 · FY2023 · DA
Enhancing Substance Use Treatment Services to Decrease Dropout and Improve Outpatient Treatment Utilization in Emerging Adults
$765,718Kristyn Zajac · University Of Connecticut Sch Of Med/Dnt · R01 · FY2021 · DA
Context and Subjective Experience Surrounding Dual Cigarette and E Cigarette Use
$765,564Robin J Mermelstein · University Of Illinois At Chicago · R01 · FY2019 · CA
Endocannabinoid roles in neurochemical and reinforcing effects of abused drugs
$765,562Gianluigi Tanda · National Institute On Drug Abuse · ZIA · FY2017 · DA
Evaluation of Clinical Effectiveness, Cost, and Implementation Factors to Optimize Scalability of Treatment for Co-Occurring SUD and PTSD Among Teens
$765,488Carla Kmett Danielson · Medical University Of South Carolina · R01 · FY2021 · DA
Cherokee Nation Prevention Trial: Interactive Effects of Environment & SBIRT
$765,466Kelli Ann Komro · University Of Florida · R01 · FY2012 · AA
Novel PET imaging agents for understanding glutamine addiction in cancer
$765,328Hank F Kung · University Of Pennsylvania · R01 · FY2013 · CA
Data Core
$765,040Mingyao Li · University Of Pennsylvania · U19 · FY2023 · NS
Optimization and preclinical development of FAAH inhibitors for smoking cessation
$765,000Daniele Piomelli · University Of California-Irvine · DP1 · FY2010 · DA
Core Center for Translational Addiction Sciences
$765,000Kathryn A. Cunningham · University Of Texas Med Br Galveston · P30 · FY2010 · DA
Core Center for Translational Addiction Sciences
$765,000Kathryn A. Cunningham · University Of Texas Med Br Galveston · P30 · FY2009 · DA
Clinical Laboratory Core
$764,901Jennifer W Tidey · Brown University · P20 · FY2019 · GM